5Dagan R,Leibovitz E,Greenberg D,et al.Early eradication of pathogens from middle ear fluid during antibiotic treatment is associated with improved clinical outcome.Pediatr Infect Dis J,1998,17:776-782.
6Jacobs MR.How can we predict bacterial eradication? Int J Infect Dis,2003,7: Suppl 1 :13-20.
7Pechere JC,Lacey L.Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis.J Antimicrob Chemother,2000,45:19-24.
8Andes D,Craig WA.Animal model pharmacokinetics and pharmacodynamics: a critical review.Int J Antimicrob Agents,2002,19:261-268.
9Thomas JK,Forrest A,Bhavnani SM,et al.Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy.Antimcrob Agents Chemother,1998,42:521-527.
10Song JH.Introduction: the goals of antimicrobial therapy.Int J Infect Dis,2003,7 Suppl 1 :S1-4.
